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1. Introduction 
The unique availability of two groups of highly 
specific inhibitors of the ADP, ATP carrier has made 
it possible to gain a highly advanced insight into the 
carrier mechanism on a molecular level. In particular, 
the binding studies with ADP, ATP [l] and the inhi- 
bitors, atractylate (ATR), carboxyatractylate (CAT) 
[2-41 and bongkrekate (BKA) [3,5-71 led us in 
elaborate studies since 1969 to the discovery of the 
reorientation mechanism [6-81 and its molecular 
version which we called in 1976 the ‘gated pore’ 
mechanism [9-l 11. 
As a consequence the carrier has been postulated 
to exist essentially in two major states, alternating 
in the translocation process, the ‘c-state’ where the 
single binding site is facing the cytosolic side of the 
membrane and can bind CAT, and the ‘m-state’ facing 
the matrix side and can bind BKA. In both states the 
binding site has a high specificity for ADP and ATP. 
Different from our models, a separate binding site 
of ATR was proposed to be located in a control sub- 
unit linked to the carrier subunit [12,13]. Lauquin 
and Vignais in 1976 maintained that also BKA and 
ADP bound to separate sites and the carrier forms a 
ternary BKA-ADP protein complex [14,15]. Our 
model explicitly excludes this complex, which was 
first postulated in our binding studies with BKA in 
1970 [5], but then explicitly ruled out by an abun- 
dance of evidence since 1972 [6,7]. Then, our model 
of a fixed gated pore in a dimeric protein with binding 
sites for substrate and inhibitors at the same protein 
was adopted [16,17]. The localization of the ATR 
binding site on the outer and that for BKA on the 
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inner membrane face, were also adopted but main- 
tained that both sides are different and do not overlap 
[16,17]. This modification was based on the finding 
that UV radiation inhibited binding of ATR but not 
of BKA to mitochondria [ 14,161. 
Here we stress that also amino acid reagents such 
as phenylglyoxal [ 181 may spare binding of BKA 
when inhibiting that of CAT. However, we show by 
a comparison with NEM results [9,11 ,191 that these 
findings can be accommodated to the single reorienting 
site model by assuming that these amino acid modifi- 
cations stabilize the m-state, thus preventing CAT 
binding. There is no evidence for the localization of 
these amino acid modifications at the CAT binding 
site and, consequently, for separate binding sites for 
CAT and BKA, as postulated in [ 171. 
2. Methods 
Phenylglyoxal was obtained from Merck and dis- 
solved in ethanol. [3H]BKA [20] and [3H]CAT [21] 
were prepared as in [22]. Beef heart mitochondria 
were prepared as described. 
For treatment with phenylglyoxal, beef heart 
mitochondria were incubated in 40 mM borate buffer 
at 1 mg protein/ml at 2O”C, and for 20 min. The 
medium also contained 100 PM ATP. Then to each 
sample, 10 PM [3H]CAT or [3H]BKA were added 
and after another 5 min mitochondria were centri- 
fuged for 10 min at 8000 X g. Supernatant was care- 
fully removed and the pellets dissolved in SDS for 
liquid scintillation counting. 
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3. Results and discussion 
The experimental results are a brief excerpt from 
more extensive studies of the effects of the amino 
acid reagent phenylglyoxal on the ADP, ATP carrier. 
Phenylglyoxal has been known to be a relatively speci- 
fic reagent for arginine 1181. It can be visualized to 
aim at the binding center of the ADP, ATP carrier 
which should contain cationic amino acid residues 
for binding the highly negatively charged ligands 
ADP, ATP and CAT as well as BKA. No divalent 
cation is involved in the binding. Three compensating 
cationic charges have been proposed to be the binding 
center [9]. In first experiments in fact, phenylglyoxal 
was found to inhibit the ADP, ATP exchange, 
although only at high concentrations (unpublished). 
In this context some results about the influence 
of phenylglyoxal on the binding CAT and BKA to 
mitochondria are presented. These are compared with 
the influence of the SH-reagent NEM on the binding 
of both inhibitors, which does not attack the binding 
center but rather to fix the carrier in the m-state [ 191. 
The influence of phenylglyoxal on the binding of 
either [3H]CAT or [3H]BKA to beef heart mito- 
chondria is shown in fig.1. Mitochondria were incu- 
bated with increasing concentration of phenylglyoxal 
before addition of CAT or BKA. There is no change 
of the binding capacity for [3H] BKA whereas the 
binding of [3H] CAT is increasingly suppressed. In a 
parallel experiment mitochondria were exposed to 
increasing amounts of NEM. Similarly the binding 
of [“HI BKA remains undisturbed whereby the bind- 
ing of [3H]CAT becomes largely inhibited. In all 
samples ATP is present to facilitate the transition 
between the c- and m-states and thus to make the 
binding centers more accessible to either BKA or 
CAT by the ATP catalyzed transition between the 
c- and m-states. The effect of NEM on the differential 
binding of CAT and BKA has been reported [ 111. 
These results show that phenylglyoxal has principally 
similar effects on the binding of both ligands as NEM. 
We also examined how phenylglyoxal influences 
the mutual displacement of CAT and BKA (fig.2). 
Untreated and phenylglyoxal-treated mitochondria 
were incubated either first with CAT and subse- 
quently with BKA or vice versa. After CAT is added, 
BKA is still bound to some extent as in these mito- 
chondria not all carrier sites are amenable to CAT. 
Also some unspecific BKA absorption to the mem- 
branes contributes to the binding. Comparison with 
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Fig.1. Comparison of the influence phenylglyoxal and ot 
NEM on the binding of CAT and BKA to mitochondria. Beef 
heart mitochondria were treated with increasing amounts of 
phenylglyoxal and NEM and after 20 min [3H]CAT or [“HI- 
BKA under saturating amounts are added. The amount of 
CAT and BKA bound is measured in the pellets after centri- 
fugation of the mitochondria (PheC. phenylglyoxal). 
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Fig.2. The promotion by phenylglyoxal of BKA binding in 
favor of CAT in mitochondria. Sequential additions of either 
CAT and BKA or vice versa on phenylglyoxal-treated or 
untreated mitochondria. Beef heart mitochondria were pre- 
treated with phenylglyoxal for 20 min. Then the first ligand, 
and 5 min later the second ligand are added (PG. phenyl- 
glyoxal). 
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the control shows that subsequent addition of BKA 
does not remove any CAT. However, in the presence 
of phenylglyoxal the CAT binding is suppressed by 
-50% and subsequently added BKA now can bind 
to a correspondingly larger share of sites. When first 
BKA is added, CAT binding is diminished and in the 
phenylglyoxal-treated mitochondria, CAT binding 
is still more decreased whereas BKA binding remains 
unchanged. Phenylglyoxal treatment obviously 
increases the susceptibility to BKA by suppressing 
CAT binding. 
It can be concluded that the arginine reagent 
phenylglyoxal inactivates CAT but not BKA binding 
similarly as the SH-reagent NEM and as UV radiation. 
Among these phenylglyoxal comes closest to a rea- 
gent which might attack the binding center since 
cationic amino acid such as arginine ought to par- 
ticipate in the binding of the anionic phosphate, sul- 
fate or carboxylate groups present in the 3 types of 
ligands, ADP and ATP, CAT and BKA. This seems to 
be confirmed by inhibition of CAT binding and of 
the ADP, ATP exchange (unpublished). At a first 
sight, the insensitivity of BKA binding to phenyl- 
glyoxal then appears to indicate that CAT and BKA, 
in particular with their anionic groups, occupy dif- 
ferent binding centers at the carrier. This argument 
was advanced in [ 161 for the results of UV radiation 
and it now seems to be substantiated more precisely 
with the arginine reagent. 
The pitfalls of this reasoning become apparent 
by the comparison with the SH-reagent NEM. Essen- 
tially the same effect on the binding were found with 
NEM and with phenylglyoxal or by UV radiation, 
with the difference that the effect of NEM is more 
clear-cut. NEM has a further advantage because the 
specific, ADP-dependent incorporation to SH-groups/ 
carrier molecule can be studied, whereas phenyl- 
glyoxal incorporation is rather sluggish and does not 
permit to differentiate between the 17 arginme 
groups in the molecule [23]. The rapid reaction of 
NEM allows to segregate an ADP stimulated from an 
unspecific reaction. 
According to an unreflecting interpretation of 
these results, also the NEM reactive SH-group should 
be at the CAT binding site but not at the BKA bind- 
ing site. A more penetrating interpretation encom- 
pasing the various effects of ADP, uncoupler, inhibi- 
tors on the NEM interaction with the carrier could be 
derived from our reorienting site mechanism of the 
ADP, ATP carrier. This interpretation is shown in 
(UV,NEM) PG PG (NEM,UV) 
-PG *(NEM,UV) 
CAT-Cc BKA-Cm*PG* (NEM,UV) 
Fig.3. The transition between the c- and m-state of the carrier 
and interaction of the ammo acid reagents phenylglyoxal and 
NEM. The scheme is a slight modification of that previously 
published for the reaction of NEM. The reaction of phenyl- 
glyoxal with the protein only in the m-state is to represent 
those arginine groups, the inhibition of which are essentially 
blocking the transition between the c- and m-state (PG, 
phenylglyoxal; UV, UV irradiation). 
the reaction scheme of fig.3 which represents the 
reaction step of the reorienting mechanism [7,8] 
modified to include the interaction of phenylglyoxal. 
Only a few of the experimental arguments for this 
scheme can be mentioned here. An extensive account 
of the NEM-effects will be published shortly (Aquila 
and Klingenberg). A crucial result is the unmasking of 
the SH-group to NEM in the presence of ADP. By 
analogy to the ‘unmasking’ of BKA binding capa- 
bility, we postulated that the SH-group becomes 
reactive only when the carrier is brought into the 
m-state. All the experiments with the carrier in mito- 
chondria and in the isolated purified state have been 
in agreement with this concept. The broader evidence 
is just contrary to what might superficially tell only 
the binding data, i.e., that NEM reacts with the car- 
rier at the CAT binding site, in the c-state, and that 
the SH-group is masked in the m-state and therefore 
NEM does not interact with BKA binding site. 
Although with phenylglyoxal the evidence is less 
powerful, by analogy to the effects of NEM we propose 
basically the same interpretation. In the m-state one or 
more arginine groups are unmasked and after reaction 
with arginine the transition to the c-state and thus 
binding of CAT but not of BKA is inhibited. The 
involved arginine groups may not be part of the 
binding center, similar as the ‘essential’ SH-group. 
Actually the relative ineffectiveness of arginine rea- 
gents may indicate that these arginine groups are 
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more peripheral to the binding center. Other sup- 
porting evidence for the phenylglyoxal mechanism 
to be published elsewhere, is also less precise than 
that for NEM since there are considerably more 
arginine than SH-groups in the protein (17 to 3) so 
that the background differentiation of the involved 
arginine groups is more difficult, moreover, as the 
arginine groups are much less reactive than SH-groups. 
Thus an ADP dependence of the phenylglyoxal effect 
is difficult to demonstrate (unpublished). 
We feel that also the UV irradiation falls into the 
same category, i.e., differential amino acid modifica- 
tion between c- and m-state. In fact here the analogy 
to NEM is more stringent, as ADP or ATP are found 
to accelerate the UV inactivation of ATR binding 
[ 171. The authors, however, interpret this unexpected 
observation by assuming a closer spatial relation of the 
binding site for ADP to that for ATR than for BKA. 
In contrast, with the reorientation mechanism the 
ADP effect is to be predicted and affords a crucial 
criterion for interpreting the effect as a c-m-state 
transition. 
We can conclude that these results do not con- 
tradict, as claimed in [17], but rather support our 
model of a single binding center for substrate and 
both inhibitor types. Of course, this does not mean 
that the binding amino acid regions are identical for 
all ligands and for both states. For clarification we 
reproduce the ‘gated pore’ model of the reorienting 
carrier sites as it was pictured in 1976 (fig.4A) [ 111. 
A single binding center is visualized to be located in 
the central channel between the two subunits of the 
carrier dimer. It is indicated that the center changes 
strongly its ‘configuration’ between the two states. 
This is reflected in the change of specificity for bind- 
ing CAT to that for binding BKA in the other state. 
The center has a common core sharing the binding 
both in the c- and m-state, but additional, different 
regions along the channels either directed to the 
c-side or the m-side ought to interact with the sub- 
strate. As shown in fig.4B [IO] the larger molecules 
of the inhibitors should occupy additional areas on 
binding, again retaining a common binding area. At 
least, the reported differential effects on CAT and 
BKA binding cannot be interpreted to indicate inter- 
action with the amino acid set exclusively involved 
in CAT binding, independent of whether there is a 
common binding center or the binding sites for CAT 
and BKA are completely separated. 
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Fig.4. The ‘gated pore’ model of the dimes ADP, ATP carrier 
with a common reorienting binding center for substrates and 
inhibitors as presented in 1975 and 1976. (A) The scheme 
indicates that in the c- and m-state the binding center employs 
a common set of amino acids and additional non-common 
ammo acid sets [ 111. CB) The binding center of the ADP, ATP 
carrier in the c- and m-state, with the space-filling molecules 
of the ligands ADP, CAT and BKA in the c-and m-state [ 1’01. 
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